ZSPC.OQBZspace, INC

8-K: zSpace Secures Up to $30 Million Equity Financing Facility with Tumim Stone Capital

Sentiment:

Equity Financing Agreement


zSpace, Inc. has entered into a common stock purchase agreement with Tumim Stone Capital LLC, providing the company with the right to sell up to $30 million in newly issued common stock over 24 months, subject to market conditions and limitations.

Capital raisezSpace, Inc. has the right to sell up to $30,000,000 worth of newly issued common stock to Tumim Stone Capital LLC over a period of up to 24 months.Sales are at the Company's sole discretion and will be made through "VWAP Purchases" at 97% of the Volume Weighted Average Price (VWAP).The Company will issue $150,000 worth of common stock as an initial commitment fee and an additional $150,000 worth of common stock upon receiving $10,000,000 in cash proceeds from sales to Tumim.The capital raise is subject to a Nasdaq Exchange Cap of 19.99% of outstanding shares (4,656,828 shares) unless stockholder approval is obtained, and a beneficial ownership limitation for Tumim of 4.99% (adjustable to 9.99%).Proceeds are intended for operating expenses, working capital, and other general corporate purposes.

Summary

  • zSpace, Inc. (the "Company") has secured an equity financing facility with Tumim Stone Capital LLC ("Tumim") through a Common Stock Purchase Agreement and a Registration Rights Agreement.
  • The Company has the right, but not the obligation, to sell up to $30,000,000 worth of newly issued common stock to Tumim over a period of up to 24 months.
  • Sales will occur through "VWAP Purchases" at the Company's sole discretion, subject to conditions including the common stock's closing price on Nasdaq being above $0.01.
  • The purchase price for shares in a VWAP Purchase will be 97% of the Volume Weighted Average Price (VWAP) during a 1-day or 3-day valuation period.
  • The Company will reimburse Tumim for up to $25,000 in reasonable out-of-pocket expenses, including legal fees.
  • As consideration, Tumim will receive "Commitment Shares": an initial $150,000 worth of common stock upon the filing of the Initial Registration Statement, and an additional $150,000 worth of common stock once the Company receives $10,000,000 in cash proceeds from sales to Tumim.
  • The Company is obligated to file a registration statement (Form S-1) with the SEC to register the resale of shares issued to Tumim and maintain its effectiveness.
  • The agreement includes limitations on the number of shares that can be issued, specifically a Nasdaq Exchange Cap of 19.99% of outstanding shares (4,656,828 shares) unless stockholder approval is obtained, and a beneficial ownership limitation for Tumim of 4.99% (adjustable to 9.99% with 61-day notice).
  • Proceeds from sales are planned for operating expenses, working capital, and general corporate purposes.

Sentiment

Score: 6

Explanation: The agreement provides a flexible capital access mechanism, which is positive for liquidity and operations. However, the potential for significant dilution and the commitment fees/expenses represent a cost. The limitations on the facility (Exchange Cap, beneficial ownership) and the prohibition on other variable rate transactions are neutral to slightly negative, as they constrain future financing flexibility. Overall, it's a necessary but potentially costly step for a company seeking funding.

Positives

  • Secures a flexible equity financing facility of up to $30 million, providing potential access to capital for operating expenses, working capital, and general corporate purposes.
  • Sales of common stock are at the Company's sole option, allowing control over timing and amount based on market conditions and funding needs.
  • The Company is not obligated to sell securities under the arrangement.
  • The agreement includes a 3% discount to VWAP, which is a relatively standard discount for such facilities.
  • The Company retains flexibility to terminate the agreement at any time after Commencement with 5 trading days' notice, at no cost or penalty.

Negatives

  • Potential for significant dilution to existing stockholders due to the issuance of new common stock, as explicitly acknowledged by the Company.
  • The "Exchange Cap" limits the number of shares that can be issued without stockholder approval (19.99% or 4,656,828 shares), which could restrict the full utilization of the $30 million facility if the stock price is low.
  • The "Beneficial Ownership Limitation" restricts Tumim's ownership to 4.99% (or 9.99% with notice), which could also limit the amount of capital raised if Tumim approaches this threshold.
  • The Company is prohibited from engaging in "Variable Rate Transactions" (dilutive financing with variable pricing or reset features) for 24 months, with limited exceptions, which could restrict future financing options.
  • The Company must pay Tumim $25,000 for out-of-pocket expenses and issue $300,000 worth of commitment shares, regardless of whether the full facility is utilized.
  • The minimum closing price for a VWAP purchase is $0.01, meaning if the stock price falls below this, the Company cannot utilize the facility.

Risks

  • Dilution Risk: Issuance of shares could cause significant dilution to existing stockholders and increase the number of outstanding common stock shares.
  • Market Price Volatility: Actual sales and proceeds depend on market conditions and the trading price of the common stock.
  • Exchange Cap Limitation: The 19.99% Exchange Cap (4,656,828 shares) may limit the amount of capital that can be raised without obtaining stockholder approval, which the Company will use reasonable best efforts to obtain by October 31, 2025, and every 90 days thereafter if not obtained.
  • Beneficial Ownership Limitation: Tumim's beneficial ownership limit of 4.99% (or 9.99%) could restrict the amount of shares Tumim can purchase.
  • Regulatory Compliance: Failure to comply with SEC or Nasdaq rules (e.g., maintaining listing, timely filings, registration statement effectiveness) could impact the ability to draw funds.
  • Operational Funding Dependence: The Company plans to use proceeds for operating expenses and working capital, indicating a reliance on this facility for ongoing operations.
  • Litigation Risk: Potential for legal proceedings or regulatory matters that could have a Material Adverse Effect, as generally disclosed in SEC filings.
  • Material Adverse Effect: The agreement can be terminated if a Material Adverse Effect occurs and is continuing, or if certain other adverse events related to trading or bankruptcy occur.

Future Outlook

zSpace, Inc. intends to use any net proceeds from the sale of shares under the Purchase Agreement for operating expenses, working capital, and other general corporate purposes. The Company will also seek stockholder approval by October 31, 2025, and every 90 days thereafter if needed, to issue shares in excess of the 19.99% Nasdaq Exchange Cap.

Management Comments

  • The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arms-length purchaser with respect to this Agreement, the Registration Rights Agreement and the transactions contemplated by the Transaction Documents.
  • The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement or the Registration Rights Agreement and the transactions contemplated by the Transaction Documents, and any advice given by the Investor or any of its representatives or agents in connection therewith is merely incidental to the Investor’s acquisition of the Shares.
  • The Company further represents to the Investor that the Company’s decision to enter into the Transaction Documents to which it is a party has been based solely on the independent evaluation of the transactions contemplated thereby by the Company and its representatives.

Industry Context

This equity financing facility provides zSpace, Inc. with a flexible funding mechanism, common among smaller or emerging growth companies, to support ongoing operations and strategic initiatives without the immediate pressure of a fixed-price offering. The structure, which allows the company to control the timing and amount of sales based on market conditions, is a typical approach for companies seeking to manage dilution while maintaining access to capital. The limitations, such as the Nasdaq Exchange Cap and beneficial ownership limits, are standard regulatory considerations for such agreements.

Comparison to Industry Standards

  • The 3% discount to VWAP (97% of VWAP) is a common pricing mechanism in at-the-market (ATM) or equity line facilities, aligning with typical industry practices for such flexible funding arrangements.
  • The 19.99% Exchange Cap is a standard Nasdaq listing rule (Rule 5635(d)) that requires shareholder approval for issuances exceeding this threshold, unless the transaction is 'at-market.'
  • The 4.99% beneficial ownership limitation is a common provision in such agreements to prevent the investor from triggering reporting requirements under Section 13(d) of the Exchange Act, which would require more extensive public disclosure of their holdings.
  • The prohibition on 'Variable Rate Transactions' is a protective measure often included in these agreements to prevent the company from entering into other highly dilutive financing arrangements that could undermine the current facility.

Stakeholder Impact

  • Shareholders: Potential for significant dilution due to the issuance of new common stock. The value of existing shares could decrease if the new shares are issued at a lower price than the current market price.
  • Company Operations: Provides access to capital for operating expenses, working capital, and general corporate purposes, which could support ongoing business activities and growth initiatives.
  • Creditors: The capital raise could improve the company's liquidity and financial stability, potentially reducing credit risk.

Next Steps

  • File a Current Report on Form 8-K disclosing the agreement.
  • File a Form D with respect to the issuance and sale of shares within 15 calendar days.
  • File an Initial Registration Statement on Form S-1 to register the resale of shares by Tumim Stone Capital LLC.
  • Use commercially reasonable efforts to cause the Initial Registration Statement to be declared effective by the SEC.
  • File a final prospectus in connection with the effective registration statement.
  • Obtain stockholder approval to issue shares in excess of the 19.99% Nasdaq Exchange Cap by October 31, 2025, and every 90 days thereafter if not obtained.
  • Issue Initial Commitment Shares upon filing of the Initial Registration Statement or a later date specified by the Investor.
  • Issue Additional Commitment Shares upon receiving $10,000,000 in cash proceeds from sales to Tumim.
  • The Company may, at its sole discretion, direct Tumim to purchase amounts of common stock from time to time over the 24-month term.

Key Dates

DateDescription
2024-12-31End of Company's most recent audited fiscal year, and date of 2024 Form 10-K.
2025-04-11Date of Convertible Note issued by the company to 3i LP.
2025-06-26Start of period during which Investor, its agents, representatives or Affiliates did not engage in or effect any short sale or hedging transaction with respect to Common Stock.
2025-07-07Date of resolutions duly adopted by the Board of Directors of the Company approving the transactions.
2025-07-08Closing Date of the Common Stock Purchase Agreement and Registration Rights Agreement.
2025-10-31Stockholder Approval Deadline for issuing shares in excess of the Exchange Cap.
2027-07-0824-month anniversary of the Closing Date, when the Purchase Agreement automatically terminates if not earlier.

Recommendation

hold

Keywords

Equity Financing, Common Stock Purchase Agreement, SEC Filing, Form 8-K, Dilution, Capital Raise, Publicly Traded Company, Nasdaq, Tumim Stone Capital, zSpace Inc., Investment, Financial Reporting, Corporate Governance, Risk Management, Strategic Business Analysis, VWAP Purchase, Registration Rights, Commitment Shares, Exchange Cap, Beneficial Ownership Limitation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.